SHERIDAN, WYOMING – November 09, 2024 – In a significant advancement for healthcare diagnostics, bioMérieux, a world leader in in vitro diagnostics, announces the launch of VIDAS® VITAMIN B12 TOTAL, a groundbreaking automated test designed to revolutionize the detection and management of vitamin B12 deficiency. This innovative test, which received CE marking, offers a rapid and efficient method for measuring vitamin B12 concentration in human serum or plasma, providing healthcare professionals with a critical tool for accurate diagnosis and timely treatment.
Vitamin B12 plays an indispensable role in various bodily functions, including cell metabolism, DNA synthesis, and red blood cell production. Deficiency in this essential vitamin can lead to a range of health issues, notably anemia and neurological complications. Recognizing the urgent need for reliable and efficient diagnostic solutions, bioMérieux developed the VIDAS® VITAMIN B12 TOTAL test to address this prevalent health concern.
The VIDAS® VITAMIN B12 TOTAL test is expected to be available in select countries by the end of 2024, with broader availability planned for the first quarter of 2025. This phased rollout will ensure accessibility to this vital diagnostic tool for healthcare professionals and patients worldwide.
About VIDAS®
VIDAS® is a renowned multi-parameter immunoassay system widely utilized in clinical laboratories. Its user-friendly interface, combined with its accuracy and versatility, has made it a preferred choice for healthcare professionals seeking reliable and efficient diagnostic solutions. The VIDAS® platform offers a broad range of assays for diagnosing and monitoring various health conditions, making it an indispensable tool in modern healthcare settings.
"This cutting-edge test is compatible with all VIDAS® immunoassay instruments, offering labs increased efficiency and reliable tracking of results," states the official press release. This compatibility ensures seamless integration into existing laboratory workflows, enhancing productivity and streamlining diagnostic processes.
One of the key advantages of the VIDAS® VITAMIN B12 TOTAL test lies in its ability to provide precise and timely results, enabling healthcare professionals to make informed decisions regarding patient care. Early detection of vitamin B12 deficiency is crucial in preventing serious health complications, and this new test empowers healthcare providers with the information necessary for effective intervention and management.
Jennifer Zinn, Executive Director of Clinical Operations at bioMérieux, emphasized the company's unwavering commitment to innovation and providing valuable diagnostic solutions, stating that the VIDAS® range is a cornerstone of their immunoassay strategy, with continuous investment in research and development. This dedication to advancing diagnostic capabilities is exemplified by the introduction of the VIDAS® VITAMIN B12 TOTAL test, which is poised to transform the landscape of vitamin B12 deficiency diagnosis.
About bioMérieux
With a rich history spanning over 55 years, bioMérieux has established itself as a global leader in in vitro diagnostics. The company's presence in 44 countries and an extensive distribution network reaching over 160 countries underscores its commitment to providing innovative diagnostic solutions worldwide. In 2023, bioMérieux generated €3.9 billion in revenue, a testament to its dedication to improving patient health and consumer safety through the development and distribution of cutting-edge diagnostic technologies.
About Vitamin B12 Deficiency
Vitamin B12 deficiency is a prevalent condition with far-reaching health implications. It can lead to anemia, fatigue, and neurological problems, underscoring the importance of early diagnosis and treatment. By providing an accurate and efficient method for assessing vitamin B12 levels, the VIDAS® VITAMIN B12 TOTAL test is poised to play a pivotal role in combating this prevalent health concern.
Key Benefits of VIDAS® VITAMIN B12 TOTAL
* Automated quantitative test for precise measurement of vitamin B12 levels.
* Runs on the efficient and reliable VIDAS® immunoassay platform.
* Offers labs increased throughput and complete traceability of results.
* Complements the comprehensive VIDAS® routine testing menu.
* Enhances the range of tests focused on anemia diagnosis.
* Supports optimized patient management by providing accurate and timely results.
The introduction of VIDAS® VITAMIN B12 TOTAL marks a significant milestone in the field of diagnostic medicine. By providing healthcare professionals with a powerful tool for detecting and managing vitamin B12 deficiency, bioMérieux reaffirms its commitment to delivering innovative solutions that enhance patient care and improve global health outcomes.